Status:
WITHDRAWN
Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
Lead Sponsor:
Soroka University Medical Center
Collaborating Sponsors:
Israel Cancer Association
Conditions:
Ulcer
Wounds and Injuries
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Cutaneous cancer-related pain is difficult to treat. These patients are often prescribed high systemic dosages of opioids. Yet, many patients continue to report pain while experiencing dose-limiting s...
Eligibility Criteria
Inclusion
- Moderate to severe resting pain (scores above 5/10).
- Stable analgesic regimen.
- No surgical interventions planned during the study period.
- Able to self-assess pain and report it.
- Hospitalized or receiving home care for Stage I; out-patients or receiving home care for Stage II.
- Wound not infected or covered with necrotic tissue.
Exclusion
- True sensitivity to opioids
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2012
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00306020
Start Date
January 1 2006
End Date
June 1 2012
Last Update
July 4 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.